文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛消化、代谢与肾脏急症

全国9省市新型冠状病毒肺炎临床治疗问卷调查

[Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01

2020年2月28日对参与新冠肺炎治疗的医务人员进行在线问卷调查,内容涵盖药物治疗、呼吸支持、镇静镇痛、连续性肾脏替代治疗(CRRT)和体外膜肺氧合(ECMO)等。共1103人应答,699人参与治疗,最终来自9省市的432名医生和170名护士提交有效问卷。医生问卷显示:超过95%的医生会对任何严重程度患者进行抗病毒治疗,主要药物为α-干扰素(69.5%)、洛匹那韦/利托那韦(65.0%)、阿比多尔(60.0%)和利巴韦林(55.7%);95.5%的医生会常规给重症和危重症患者使用抗生素;94.0%同意使用低剂量糖皮质激素;约2/3医生对有创通气危重症患者实施肺复张或俯卧位;79.0%偏好深镇静;约1/3认为应早期启动CRRT,近1/3建议更积极使用ECMO。结论认为医务人员熟悉国家诊疗方案并愿意遵循,但对新发疾病认识有限且存在争议,需进一步实践培训和更多循证证据。

要点

  • 超过95%的医生表示无论疾病严重程度均会进行抗病毒治疗,主要药物为α-干扰素(69.5%)、洛匹那韦/利托那韦(65.0%)、阿比多尔(60.0%)、利巴韦林(55.7%)。
  • 95.5%的医生会常规给重症和危重症患者处方抗生素,94.0%同意使用低剂量糖皮质激素治疗重症和危重症患者。
  • 约2/3的医生对有创通气危重症患者实施肺复张或俯卧位治疗,79.0%的医生偏好对有创通气患者使用深镇静。
  • 约1/3的医生认为应早期启动CRRT,近1/3的医生建议对危重症患者更积极使用ECMO。
  • 参与调查的医生主要来自湖北(29.2%)、河南(24.5%)、贵州(22.7%)、广西(14.6%)等,55.4%来自三级甲等医院,56.4%具有高级职称。

适用人群与场景

  • 参与新冠肺炎治疗的医务人员,最终分析432名医生和170名护士的有效问卷,来自9省市。
  • 医生中53.7%(232名)参与轻型新冠肺炎治疗,46.3%(200名)参与重型和危重型患者治疗。

处置流程与药物剂量

  • 超过95%的医生会对任何严重程度的新冠肺炎患者进行抗病毒治疗,主要药物包括α-干扰素(69.5%)、洛匹那韦/利托那韦(65.0%)、阿比多尔(60.0%)和利巴韦林(55.7%)。
  • 95.5%的医生会常规给重症和危重症患者处方抗生素。
  • 94.0%的医生同意给重症和危重症患者使用低剂量糖皮质激素治疗。
  • 约2/3的医生对有创通气的危重症患者实施肺复张或俯卧位治疗。
  • 79.0%的医生偏好对有创通气患者使用深镇静。
  • 约1/3的医生认为应早期启动CRRT,近1/3的医生建议对危重症患者更积极使用ECMO。

研究设计与关键结果

  • 全国9省市在线问卷调查,2020年2月28日实施,共1103人应答,699人参与新冠肺炎治疗,最终432名医生和170名护士提交有效问卷。
  • 医生主要来自湖北(29.2%)、河南(24.5%)、贵州(22.7%)、广西(14.6%)等,55.4%来自三级甲等医院,56.4%具有高级职称。
  • 超过95%的医生表示无论疾病严重程度均会进行抗病毒治疗,药物选择与国家诊疗方案高度一致。
  • 95.5%的医生会常规给重症和危重症患者使用抗生素,94.0%同意使用低剂量糖皮质激素。
  • 约2/3的医生对有创通气危重症患者实施肺复张或俯卧位,79.0%偏好深镇静;约1/3认为应早期启动CRRT,近1/3建议更积极使用ECMO。

证据类型、等级与局限

  • 证据类型:全国性在线问卷调查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 调查显示医务人员熟悉国家新冠肺炎诊疗方案并愿意遵循,但作为新发疾病,对新冠肺炎的认识有限且仍存在诸多争议。
  • 作者认为需要进一步实践培训使临床医生更了解该疾病,并需要更多循证证据指导临床治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 1 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the clinical treatment and assess the knowledge and use of the coronavirus disease 2019 (COVID-19) treatment plan issued by the nation.

METHODS: A nationwide questionnaire survey on line was administered to medical staffs involved in COVID-19 treatment on February 28th, 2020. The questionnaire included drug treatment, respiratory support therapy, sedation and analgesia, continuous renal replacement therapy (CRRT) and extracorporeal membrane oxygenation (ECMO), etc.

RESULTS: There were 1 103 respondents, of whom 699 (504 doctors and 195 nurses) participated in the treatment of COVID-19. Finally, 432 doctors and 170 nurses from 9 provinces submitted valid questionnaires. The results of the questionnaire surveys of doctors and nurses were basically the same. Considering that doctors dominated in the diagnosis and treatment of COVID-19, the results of the questionnaires of doctors were mainly analyzed. The doctors participating in the survey were mainly from Hubei (29.2%), followed by Henan (24.5%), Guizhou (22.7%), and Guangxi (14.6%), etc. 55.4% of the doctors came from tertiary three hospitals, and most of them have senior titles (56.4%). 232 doctors (53.7%) participated in the treatment of mild COVID-19, and 200 doctors (46.3%) participated in the treatment of severe and critically ill patients. More than 95% of the doctors expressed that they would carry out antiviral treatment for patients with COVID-19 regardless of disease severity. The main antiviral drugs included α-interferon (69.5%), lopinavir/ritonavir (65.0%), abidol (60.0%), and ribavirin (55.7%). The choice of antiviral drugs was highly consistent with the national treatment programs of COVID-19. At the same time, 95.5% of doctors would routinely prescribe antibiotics to severe and critically ill patients. 94.0% of doctors agreed to prescribe low-dose glucocorticoid therapy to severe and critically ill patients. About 2/3 of doctors would perform lung recruitment or prone position treatment for critical patients with invasive ventilation. 79.0% of doctors preferred to use deep sedation for patients with invasive ventilation. About 1/3 of doctors believed that CRRT should be initiated early, and nearly 1/3 of doctors suggested that ECMO should be used more aggressively in critically ill patients.

CONCLUSIONS: Medical staffs are familiar with the national treatment plan of COVID-19 and willing to follow it. However, as a new disease, we have limited knowledge about COVID-19 and there are still many controversies. Further practical training is needed to make clinicians more aware of the disease, and more evidence-based evidence is needed to guide clinical treatment.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu S, Ding X, Cao J, et al. [Nationwide survey on clinical treatment of coronavirus disease 2019 in 9 provinces and municipalities]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32527340. doi:10.3760/cma.j.cn121430-20200313-00338

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。